They have received the results from the 3rd party, there are a number of staff with degrees in their field who should be able to have this data ready to present to investors before the CR. I think the "missed projections" argument has been and gone, it's now in their hands, if the results are good there is no reason for them not to release a well put together press release saying here are our findings from the phase 2 human trials, now let us raise credit to the tune of 30,000,000 diluting shares and options rather than 70,000,000 because we know how to run a business.
BIT Price at posting:
6.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)